This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J.A.V. Coates, N. Cammack, H.J. Jenkinson, A.J. Jowett, M.I. Jowett, B.A. Pearson, C.R. Penn, P.L. Rouse, K.C. Viner, and J.M. Cameron. (−)2′-Deoxy-3′-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication In Vitro. Antimicrob. Agents Chemother. 36:733–739 (1992).
J.M. Pludda, T.P. Cooley, J.S.G. Montaner, L.E. Shay, N.E. Reinhalter, S.N. Warthan, J. Reudy, H.M. Hirst, C.A. Vicary, J.B. Quinn, G.J. Yuen, M.A. Wainberg, M. Rubin, and R. Yarchoan. A Phase I/II Study of (−)2′-deoxy-3′-thiacytidine (Lamivudine) in patients with advanced human immunodeficiency virus infection. J Infect. Dis. 171:1438–1447 (1995).
P.A. Furman, J.A. Fyfe, M.H. St Clair, K. Weinhold, J.L. Rideout, G.A. Freeman, S. Nusinoff Lehrman, D.P. Bolognesi, S. Broder, H. Mitsuya, and D.W. Barry. Phosphorylation of 3′-azido-3′-deoxythimidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc. Natl. Acad. Sci. 83:8333–8337 (1986).
H. Mitsuya, S. Broder. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associate virus (HTLV-III/LAV) by 2′,3′-dideoxynucleosides. Proc. Natl. Acad. Sc. 83:1911–1915 (1986).
M.H. St Clair, C.A. Richards, T. Spector, K.J. Weinhold, W.H. Miller, A.J. Langlois, and P.A. Furman. 3′-Azido-3′-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase. Antimicrob. Agents. Chemother. 31:1972–1977 (1987).
B.L. Robbins, B.H. Waibel, and A. Fridland. Quantitation of intracellular zidovudine phosphates by use of combined cartridge-radio immunoassay methodology. Antimicrob. Agents Chemother. 40:2651–2654 (1996).
D.Z. D’Argenio and A. Schumitzky. ADAPT II User’s Guide: Pharmacokinetic/Pharmacodynamic Systems Analysis Software. University of Southern California, Los Angeles, 1997.
M.A. Cabrita, S.A. Baldwin, J.D. Young, and C.E. Cass. Molecular biology and regulation of nucleoside and nucleobase transporter proteins in eukaryotes and prokaryotes. Biochem. Cell Biol. 80:623–638 (2002).
C.N. Chang, S.L. Doong, J.H. Zhou, H.W. Beach, L.S Jeong, C.K. Ch, C.H. Tsai, and Y.C. Cheng. Deoxycytidine deaminase-resistant stereoisomer is the active form of ()-2′3′-dideoxy-3′-thiacytidine, in the inhibition of hepatitis B virus replication. J. Biol. Chem. 267:13938–13942 (1992).
C.N. Chang, V. Skalski, J.H. Zhou, and Y.C. Cheng, Biochemical pharmacology of (+)-and (−)-2′,3′-dideoxy-3′-thiacytidine as anti-hepatitis B virus agent. J. Biol. Chem. 267:22414–22420 (1992).
J.Y. Liou, G.E. Dutschman,, W. Lam, Z. Jiang, and Y.C. Cheng. Characterization of human UMP/CMPkinase and its phosphorylation of D and L-form deoxycytidine analogue monophosphates. Cancer Research 62:1624–1631 (2002).
P. Kriehnan, J.Y. Liou, and Y.C. Cheng. Phosphorylation of pyrimidine L-deoxynucleoside analog diphosphates. J. Biol. Chem. 277:31593–31600 (2002).
P. Krishnan, Q. Fu, W. Lam, J.Y. Liou, G. Dutschman, and Y.C. Cheng, Phosphorylation of pyrimidine deoxynucleoside analog diphosphates. J. Biol. Chem. 277:5453–5459 (2002).
A. Kreimeyer, B. Schneider, R. Sarfati, A. Faraj, J.P. Sommadossi, M. Veron, and D. Deville-Bonne. NDP kinase reactivity towards 3TC nucleotides. Antiviral Reasearch 50:14–156 (2001).
Kennedy E., et al. Possible metabolic functions of deoxycytidine diphosphate choline and deoxycytidine diphosphate ethanolamine. J. Biol. Chem. 234:1998–2000 (1959).
G. Spyrou, and P. Reichard. Intracellular compartmentation of deoxycytidine nucleotide pools in S phase mouse 3T3 fibroblasts. J. Biol. Chem. 264:960–964 (1989).
Y.Z. Su, P. Huang, and W. Plunkett. Functional compartmentation of dCTP Pools. J. Biol. Chem. 270:631–637 (1995).
C.V. Fletcher, S.P. Kawle, T.N. Kakuda, P.L. Anderson, D. Weller, L.R. Bushman, R.C. Brundage, and R.P. Remmel. Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons. AIDS 14:2137–2144 (2000).
O. Turriziani, J.D. Shuetz, F. Focher, C. Scagnolari, J. Sampath, M. Adachi, F. Bambacioni, E. Riva, and B. Antonelli. Impaired 2′3′-dideoxy-3′-thiacytidine accumulation in T-lymphoblastoid cells as a mechanism of acquired resistance independent of multidrug resistant protein 4 with a possible role for ATP-binding cassette C11. J. Biochem. 368:325–332 (2002).
G. Reid, P. Wiellinga, N. Zelcer, M.D. Haas, L.V. Deemter, J. Wijnholds, J. Balzarini, and P. Borst, Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. Mol. Pharmacol. 63:1094–1103 (2003).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Kluwer Academic Publishers
About this paper
Cite this paper
Zhou, Z., D’Argenio, D.Z., Robbins, B.L., Rodman, J.H. (2004). Intracellular Metabolism of Lamivudine. In: D’Argenio, D.Z. (eds) Advanced Methods of Pharmacokinetic and Pharmacodynamic Systems Analysis Volume 3. The International Series in Engineering and Computer Science, vol 765. Springer, Boston, MA. https://doi.org/10.1007/0-306-48523-0_2
Download citation
DOI: https://doi.org/10.1007/0-306-48523-0_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4020-7804-0
Online ISBN: 978-0-306-48523-7
eBook Packages: Springer Book Archive